LONDON (Alliance News) - AstraZeneca PLC on Sunday said its Lynparza drug substantially reduced the risk of disease progression or death in patients with ovarian cancer.The drug, Lynparza, Read More
LONDON (Alliance News) - AstraZeneca PLC on Tuesday said the US Food & Drug Administration has granted orphan drug designation to Lynparza for the treatment of pancreatic cancer accounts for a Read More
LONDON (Alliance News) - Stock prices in London are set to open softer on Tuesday, with focus in the UK on the latest jobs data and any Brexit developments ahead of Wednesday's summit in early UK Read More
LONDON (Alliance News) - AstraZeneca PLC on Monday said it agreed to sell commercial rights for Atacand and Atacand Plus in Europe to Cheplapharm Arzneimittel GmbH.Atacand is a receptor for Read More
LONDON (Alliance News) - FTSE 100-listed pharmaceutical giant AstraZeneca PLC said on Friday that Non-Executive Director candidate Joseph Peter has pulled out of his candidacy for the decision was Read More
LONDON (Alliance News) - Circassia Pharmaceuticals PLC on Thursday said its loss narrowed in the first half of the year due mainly to its collaboration with pharmaceutical giant AstraZeneca pharma Read More
LONDON (Alliance News) - FTSE 100 pharmaceutical giant AstraZeneca PLC reported Monday positive results from its phase three DECLARE-TIMI 58 cardiovascular outcomes trial for Farxiga, or the on up Read More
LONDON (Alliance News) - AstraZeneca PLC Chief Executive Officer Pascal Soriot has warned of widespread shortages of medicines if Britain fails to agree a customs deal with the EU, the Sunday such Read More
LONDON (Alliance News) - AstraZeneca PLC on Tuesday said the most recent trial of Fasenra showed that the asthma drug was as effective at reducing adverse events over a two-year period as it was a Read More
BRUSSELS/FRANKFURT/PARIS (Alliance News) - The European markets fluctuated between small gains and losses throughout Monday's session and ended the day with mixed results. Investors in Read More
LONDON (Alliance News) - AstraZeneca PLC said Sunday its trial of PT010 triple combination therapy in chronic obstructive pulmonary disease met eight of the nine primary lung function KRONOS Phase Read More
LONDON (Alliance News) - Stocks were higher in London early on Friday, with Investec's stock surging as it announced plans to demerge and publicly list its Asset Management arm. Read More
LONDON (Alliance News) - AstraZeneca PLC on Friday said its hairy cell leukaemia drug, Lumoxiti, has been approved by the US Food & Drug Administration.Lumoxiti has been cleared for use Read More
LONDON (Alliance News) - Stock prices in London are called for a higher open on Friday, with markets in Europe set to follow peers in the US and Asia in making gains. In UK company news, pub chain on Read More
LONDON (Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:----------FTSE 100----------GOLDMAN CUTS GROUP TO BUY - Read More
LONDON (Alliance News) - AstraZeneca PLC on Friday said its asthma drug tezepelumab has been given a breakthrough therapy designation by the US Food & Drug Administration.This has been Read More
LONDON (Alliance News) - Stocks in London are set to open marginally higher on Friday, though investors remain concerned about negative economic and political news, ahead of the key US nonfarm report Read More
LONDON (Alliance News) - FTSE 100-listed pharmaceutical company AstraZeneca PLC said Thursday it has hired former Nissan Motor Co Chief Financial Officer Joseph Peter as a non-executive will begin Read More
LONDON (Alliance News) - Pharmaceutical giant AstraZeneca PLC on Friday said the results of its trial of anifrolumab drug showed that it was not effective at treating systemic lupus TULIP 1 phase Read More
LONDON (Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:----------FTSE 100----------MERRILL LYNCH CUTS TO 'NEUTRAL' - Read More